Physician profile
Reena Sachdev
NPI 1790805729
$1,936.33
in general payments reported to CMS, 2019-2025
22 companies · $37.35 in 2025
The $37.35 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $96.06 · 2021: $331 · 2022: $385 · 2023: $343 · 2024: $297 · 2025: $37.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $238.13 | 2020-2024 | Ilumya |
| Almirall LLC | $204.00 | 2019-2024 | Klisyri, Seysara |
| Janssen Biotech, INC. | $188.02 | 2019-2024 | Simponi Aria, Remicade, Stelara |
| Incyte Corporation | $169.62 | 2021-2025 | Opzelura |
| Amgen INC. | $131.05 | 2020-2023 | Otezla |
| Abbvie INC. | $130.97 | 2019-2023 | Skyrizi |
| Pfizer INC. | $123.26 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $108.52 | 2019-2024 | |
| Leo Pharma INC. | $84.94 | 2019-2022 | |
| Galderma Laboratories, L.P. | $83.31 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $81.13 | 2019-2023 | Libtayo |
| Celgene Corporation | $71.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $68.47 | 2023 | Sotyktu |
| Lilly USA, LLC | $56.91 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Biofrontera INC. | $38.08 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.57 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.07 | 2024 | Spevigo |
| Mayne Pharma Commercial LLC | $25.15 | 2019 | |
| Vyne Pharmaceuticals INC. | $22.88 | 2021 | |
| Genzyme Corporation | $22.25 | 2022 | |
| Genentech USA, INC. | $14.57 | 2019 | |
| Strata Skin Sciences, INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Sachdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.